-
Chinese pharmaceutical companies are frequently acquiring overseas companies to accelerate internationalization
Time of Update: 2022-10-25
Therefore, for pharmaceutical companies initiating mergers and acquisitions, choosing to acquire small pharmaceutical companies with R&D and production capabilities can quickly expand their product lines and cut into new fields.
-
A number of CXO heads disclosed "eye-catching" report cards in the first three quarters, and the industry is prosperous
Time of Update: 2022-10-25
Zhaoyan New Drug issued a performance forecast announcement on the evening of October 18, and it is expected to achieve a net profit attributable to the parent in the first three quarters of about 607 million to 657 million yuan, a year-on-year increase of about 144.
-
Analysis and revision of GMP deficiency in China in 2010
Time of Update: 2022-10-25
There is no doubt that China's GMP (2010 Revision), which came into effect on March 1, 2011, has played a key role in standardizing the business practices of Chinese pharmaceutical companies, promoti
-
Invisible orthodontics will also be collected! Will the market landscape change?
Time of Update: 2022-10-25
js?cdnversion='+~(-new Date()/36e5)]; Due to the high price of dental implants, the news and progress of dental implant collection in the past two years have attracted the attention of consumers.
-
Schneider Electric Live Preview Dry Goods from Clean Environment to Process Automation is coming!
Time of Update: 2022-10-25
With the rapid development of emerging technologies such as cloud computing, AI, 5G, and the Internet of Things, as well as the continuous introduction of strategies such as "Industry 4. 0" and "Made
-
With a drug market of nearly 30 billion, a large number of domestic pharmaceutical companies are competing for layout
Time of Update: 2022-10-25
js?cdnversion='+~(-new Date()/36e5)]; Recently, GlaxoSmithKline (GSK) announced that the expanded study of its recombinant herpes zoster vaccine "Xin'anlishi" has achieved positive interim results.
js?cdnversion='+~(-new Date()/36e5)]; Recently, GlaxoSmithKline (GSK) announced that the expanded study of its recombinant herpes zoster vaccine "Xin'anlishi" has achieved positive interim results.
-
Pharmaceutical companies are laying out shingles vaccines, and how is the current research and development progress
Time of Update: 2022-10-25
On October 21, multinational pharmaceutical company GlaxoSmithKline (GSK) announced positive interim results in the expansion of its recombinant herpes zoster vaccine "Xin'anlishi".
On October 21, multinational pharmaceutical company GlaxoSmithKline (GSK) announced positive interim results in the expansion of its recombinant herpes zoster vaccine "Xin'anlishi".
-
Exposure! Another batch of pharmaceutical companies were fined for producing and selling counterfeit drugs
Time of Update: 2022-10-25
According to the penalty documents, the parties purchased a total of 15kg of the above-mentioned madder from a company in Yunnan on September 2, 2021, January 24, April 27, and May 11, 2022, with a unit price of 316.
-
Novartis, Abbott, Sanofi, Merck split generic drug apocalypse!
Time of Update: 2022-10-25
Looking at the entire generic drug industry, it has been infinitely prosperous: large companies continue to buy, mergers and acquisitions and expand, are sought after by capital and leverage, and have also ushered in a surge in stock price market value; Nowadays, many products and documents are changed or discontinued through subtraction, divestiture and sale.
-
The market potential of proprietary Chinese medicine gastric medicine is huge, which has attracted many pharmaceutical companies to make efforts to grab food
Time of Update: 2022-10-25
Qingfeng Pharmaceutical is also actively deploying in the Chinese proprietary medicine gastric medicine market, and has won the production approval of monkey mushroom drink oral liquid, and Ollantic Gastro Kang tablets are expected to become the company's first Class 1 new drug in this field.
-
Since the third quarter, investment and financing in the field of medical equipment have been hot, and the financing scale of some enterprises has exceeded 5 billion yuan
Time of Update: 2022-10-25
On October 14, Fujian Provincial Joint Procurement Center for Pharmaceuticals and Devices issued an announcement "Laparoscopic Cutting Kiss/Suture Instrument Medical Consumables Inter-provincial Alliance Centralized Procurement Announcement (No. 1)", the overall price reduction is relatively moderate, import manufacturers are expected to report the volume to be seized by domestic manufacturers, domestic substitution is expected to accelerate.
-
During the year, more than 1,000 listed companies set off a wave of buybacks, and pharmaceutical companies became "frequent customers"
Time of Update: 2022-10-25
In terms of the number of repurchases, WuXi Biologics has been active in repurchases, with a total of eight repurchases in the past month, with a total capital contribution of nearly HK$1 billion and more than 20 million shares repurchased (data as of the market close on October 14).
-
Qilu exploded! 30 Class 1 new drugs dominate, and 13 blockbuster varieties have been approved
Time of Update: 2022-10-25
Since the beginning of this year, Qilu Pharmaceutical has submitted clinical applications for 6 Class 2 improved new drugs, including risperidone oral dissolving film, lenvatinib mesylate capsules, atropine sulfate eye drops, semeglutide injection, tetrahexose ganglioside sodium monosialic acid injection, oseltamivir oral lytic membrane phosphate.
-
How will the pharmaceutical equipment industry develop in the future? Four trends have long been known
Time of Update: 2022-10-25
com) According to the public data of listed pharmaceutical equipment, we can see that in the past two years, the performance of pharmaceutical machinery enterprises represented by Chutian Science and Technology, Dongfulong and other heads in China has achieved steady growth, and the overall prosperity of the industry is relatively high.
-
2023 China (Beijing) International Electronic Scale Exhibition
Time of Update: 2022-10-25
2023 China (Beijing) International Electronic Scale Exhibition China (Beijing) International Electronic Weighing Instrument Exhibition2023 【Basic Information】 When: June 16-18, 2023 Venue: Beijing Et
-
Investment and layout of artificial intelligence have become an important part of the competition of pharmaceutical giants
Time of Update: 2022-10-25
Therefore, in order to improve R&D efficiency and reduce R&D investment, with the continuous development of science and technology in recent years, more and more companies and researchers have begun to apply "artificial intelligence" to pharmaceutical R&D and market, trying to further improve the success rate of new drug research and development through artificial intelligence technology AI algorithms, reduce manufacturing costs and R&D time.
-
Journal of Experimental Medicine: Developed a new generation of tumor-specific PD1 antibody-IL15 fusion protein immunotherapy drugs
Time of Update: 2022-10-25
Anti-PD-1-IL-15-R delivers IL-15-R through PD-1 cis, specifically binding to and activating PD-1+CD8+ T cells in tumors to exert anti-tumor function As a new method of tumor treatment that has developed rapidly in recent years, tumor immunotherapy has made the situation of tumor treatment new by mobilizing the body's own immune system to fight tumors.
-
Tailor-made [Cloud Interview] The exclusive appointment channel of the Visual Environment Club is now open
Time of Update: 2022-10-25
The 2022 FERC Autumn Exhibition, which will be held from November 8th to November 14th, will be held at the same time as the ECE Summit Forum, cloud interviews, PPT presentations, and new product launches, which is your favorite?
-
Let rare diseases not be rare, 67% of domestic rare disease drugs have been included in medical insurance
Time of Update: 2022-10-25
js?cdnversion='+~(-new Date()/36e5)]; According to reports, up to now, 2860 drugs have entered the national medical insurance directory, and 67% of the listed rare disease drugs in China are among them, which greatly reduces the drug burden of patients.
-
214 drugs were taken off the network, what happened?
Time of Update: 2022-10-25
【Pharmaceutical Network Industry News】Recently, the Shandong Provincial Public Resources Exchange Center issued a notice on the withdrawal of medical consumables and in vitro diagnostic reagent produc
